FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition for cardiovascular disorders prevention and treatment is described. The said composition comprises amlodipine besylate in an amount of 1.7 to 1.72 wt %, potassium losartan in an amount of 12.22 to 12.37 wt %, and propyl gallate in an amount of 0.01 wt %, based on the total weight of the composition. The said composition has the form of a two-layer pill having two separate layers consisting of an amlodipine layer containing amlodipine besylate and propyl gallate and a layer of losartan containing potassium losartan.
EFFECT: improved composition stability in combination with simplicity of preparation.
6 cl, 21 tbl, 2 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE AND LOSARTAN | 2007 |
|
RU2401107C2 |
| COMPLEX PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE, LOSARTAN AND CHLORTHALIDONE | 2016 |
|
RU2713883C2 |
| PHARMACEUTICAL COMBINATION FORMULATION CONTAINING AMLODIPINE, LOSARTAN AND ROSUVASTATIN | 2014 |
|
RU2660586C1 |
| SOLID PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE AND LOSARTAN | 2015 |
|
RU2698703C2 |
| COFORMULATED DRUG FOR CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THERAPY | 2007 |
|
RU2464014C2 |
| PHARMACEUTICAL COMPLEX COMPOSITION CONTAINING AMLODIPINE, LOSARTAN AND ROSUVASTATIN | 2016 |
|
RU2724338C2 |
| PHARMACEUTICAL COMBINED COMPOSITION | 2016 |
|
RU2736942C2 |
| PHARMACEUTICAL PREPARATION | 2019 |
|
RU2756452C1 |
| SOLID MEDICINAL FORM INTENDED FOR TREATMENT OF ARTERIAL HYPERTENSIA AND STENOCARDIA, AND WAY OF ITS RECEPTION | 2008 |
|
RU2359672C1 |
| COMBINED CONTROLLED-RELEASE PHARMACEUTICAL AGENT CONTAINING DIHYDROPYRIDINE CALCIUM CANAL BLOCKERS AND HMG-CoA-REDUCTASE INHIBITORS | 2007 |
|
RU2450804C2 |
